Niraparib hydrochloride
99%
- Product Code: 101675
Alias:
Niraparib Hydrochloride; Niraparib Hydrochloride; Niraparib Benzoate
CAS:
1038915-64-8
Properties:
This product is for scientific research only
| Molecular Weight: | 356.85 g./mol | Molecular Formula: | C₁₉H₂₁ClN₄O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD20502397 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Niraparib hydrochloride is primarily used in the treatment of certain types of cancer, particularly ovarian, fallopian tube, and primary peritoneal cancers. It is specifically prescribed for patients who have recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer and who have responded to platinum-based chemotherapy. The drug works by inhibiting PARP enzymes, which play a crucial role in DNA repair. By blocking these enzymes, it prevents cancer cells from repairing their DNA, leading to cell death and slowing the progression of the disease. It is often used as a maintenance therapy to help delay the recurrence of cancer after initial treatment. Additionally, it has shown promise in treating other cancers with specific genetic mutations, such as BRCA mutations, where PARP inhibition can be particularly effective.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 98.5-100 |
| 1 H Nmr Spectrum | Consistent With Structure |
| Infrared Spectrum | Conforms To Structure |
| Lcms | Consistent With Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿2,760.00 |
+
-
|
| 0.050 | 10-20 days | ฿7,680.00 |
+
-
|
| 0.100 | 10-20 days | ฿14,280.00 |
+
-
|
| 0.500 | 10-20 days | ฿53,800.00 |
+
-
|
Niraparib hydrochloride
Niraparib hydrochloride is primarily used in the treatment of certain types of cancer, particularly ovarian, fallopian tube, and primary peritoneal cancers. It is specifically prescribed for patients who have recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer and who have responded to platinum-based chemotherapy. The drug works by inhibiting PARP enzymes, which play a crucial role in DNA repair. By blocking these enzymes, it prevents cancer cells from repairing their DNA, leading to cell death and slowing the progression of the disease. It is often used as a maintenance therapy to help delay the recurrence of cancer after initial treatment. Additionally, it has shown promise in treating other cancers with specific genetic mutations, such as BRCA mutations, where PARP inhibition can be particularly effective.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :